12 Industrials Stocks Moving In Friday's Pre-Market Session
ALPHA PRO TECH, LTD. ANNOUNCES $1 MILLION EXPANSION OF SHARE REPURCHASE PROGRAM FOR IMMEDIATE RELEASE
Express News | Alpha Pro Tech, Ltd. Announces $1 Million Expansion of Share Repurchase Program for Immediate Release
Alpha Pro Tech Director Garcia Sells Shares Worth $27,400
The only manufacturer of smallpox vaccine has submitted clinical data and plans to expand the scope of vaccination.
Bavarian Nordic announced that it has submitted clinical data to the European Medicines Agency to seek an expansion of the indication for its Imvanex vaccine to adolescents aged 12-17. Yesterday, Sweden, the neighboring country of Denmark, reported the first confirmed case of monkeypox, which is also the first case confirmed outside the African continent since this epidemic outbreak.
Alpha Pro Tech | 10-Q: Q2 2024 Earnings Report
Alpha Pro Tech GAAP EPS of $0.15, Revenue of $16.29M
Express News | Alpha Pro Tech Ltd: Net Sales for Q2 of 2024 Were $16.3 Mln, up 1.1%
Alpha Pro Tech 2Q Sales $16.3M >APT
Express News | Alpha Pro Tech Q2 Basic EPS USD 0.15
Express News | Alpha Pro Tech Q2 Net Income USD 1.6 Million
Press Release: Alpha Pro Tech, Ltd. Announces Second Quarter 2024 Financial Results
12 Industrials Stocks Moving In Monday's Intraday Session
Warning! US experts are concerned that if the bird flu virus mutates and evolves, a pandemic may occur.
This round of bird flu transmission has the characteristic of wide spread and extremely strong infectivity. At present, apart from Australia, relevant cases have been reported in other continents around the world. In addition to livestock, there have been several cases of human infection with avian flu virus this year, which has greatly alarmed the academic community. Former director of the US Centers for Disease Control and Prevention warned that humans may face a pandemic of bird flu.
The world's first non-COVID-19 mRNA vaccine has been approved! The market is a blue ocean. Can the RSV newcomer make a comeback?
① A "newcomer" has entered the multi-billion dollar RSV vaccine market, and it is also the world's first non-COVID mRNA vaccine approved. ② Analysis shows that whether it is recombinant protein vaccine or mRNA vaccine, which technology route can better meet clinical needs in the future will be the key evaluation. ③ The advantage of the mRNA vaccine lies in its low cost and fast R&D and production.
US and Europe speed up procurement of bird flu vaccine to deal with potential pandemic threat
The United States and Europe are taking steps to purchase or produce H5N1 avian influenza vaccines to protect at-risk poultry and dairy farm workers, vets, and laboratory technicians.
Avian flu cases spur retail investors to buy vaccine stocks
The increase in cases of avian influenza triggered investors to rush to buy vaccine stocks, and the stock prices of companies such as CureVac, Novavax, and Moderna soared. Experts recommend investing cautiously, as the development of the epidemic is uncertain.
The coronavirus hasn't disappeared yet! A new “FlIRt variant family” is spreading in the US...
① According to CDC data, the main variant of transmission in the US today is the “FlIRT” family, led by KP.2; ② KP.2 accounts for 25%; ③ medical experts warn that fLiRT has a more obvious transmission advantage and may trigger a new wave of COVID-19.
Alpha Pro Tech | 10-Q: Q1 2024 Earnings Report
Alpha Pro Tech Q1 EPS $0.05, Same YoY, Sales $13.48M Down From $13.80M YoY